77 related articles for article (PubMed ID: 27113810)
1. The rare Arg181Cys mutation in the μ opioid receptor can abolish opioid responses.
Skorpen F; von Hofacker S; Bjørngaard M; Skogholt AH; Dale O; Kaasa S; Klepstad P
Acta Anaesthesiol Scand; 2016 Sep; 60(8):1084-91. PubMed ID: 27113810
[TBL] [Abstract][Full Text] [Related]
2. The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.
Klepstad P; Rakvåg TT; Kaasa S; Holthe M; Dale O; Borchgrevink PC; Baar C; Vikan T; Krokan HE; Skorpen F
Acta Anaesthesiol Scand; 2004 Nov; 48(10):1232-9. PubMed ID: 15504181
[TBL] [Abstract][Full Text] [Related]
3. Genotyping the Mu-opioid receptor A118G polymorphism using the real-time amplification refractory mutation system: allele frequency distribution among Brazilians.
Daher M; Costa FM; Neves FA
Pain Pract; 2013 Nov; 13(8):614-20. PubMed ID: 23405975
[TBL] [Abstract][Full Text] [Related]
4. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers.
Lötsch J; Geisslinger G
Pharmacogenomics J; 2006; 6(3):200-10. PubMed ID: 16415919
[TBL] [Abstract][Full Text] [Related]
5. A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels.
Lopez Soto EJ; Raingo J
Neurosci Lett; 2012 Aug; 523(2):190-4. PubMed ID: 22796651
[TBL] [Abstract][Full Text] [Related]
6. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
7. μ-Opioid Receptor Gene A118 G Variants and Persistent Pain Symptoms Among Men and Women Experiencing Motor Vehicle Collision.
Linnstaedt SD; Hu J; Bortsov AV; Soward AC; Swor R; Jones J; Lee D; Peak D; Domeier R; Rathlev N; Hendry P; McLean SA
J Pain; 2015 Jul; 16(7):637-44. PubMed ID: 25842347
[TBL] [Abstract][Full Text] [Related]
8. Molecular biology of opioid analgesia.
Pasternak GW
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S2-9. PubMed ID: 15907642
[TBL] [Abstract][Full Text] [Related]
9. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
10. [Are polymorphisms in the mu-opioid receptor important for opioid therapy?].
Lötsch J; Freynhagen R; Geisslinger G
Schmerz; 2005 Oct; 19(5):378-82, 384-5. PubMed ID: 16133302
[TBL] [Abstract][Full Text] [Related]
11. Overview of genetic analysis of human opioid receptors.
Spampinato SM
Methods Mol Biol; 2015; 1230():3-12. PubMed ID: 25293312
[TBL] [Abstract][Full Text] [Related]
12. Micro opioid receptor A118G polymorphism and post-operative pain: opioids' effects on heterozygous patients.
De Capraris A; Cinnella G; Marolla A; Salatto P; Da Lima S; Vetuschi P; Consoletti L; Gesualdo L; Dambrosio M
Int J Immunopathol Pharmacol; 2011; 24(4):993-1004. PubMed ID: 22230405
[TBL] [Abstract][Full Text] [Related]
13. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty.
Chou WY; Yang LC; Lu HF; Ko JY; Wang CH; Lin SH; Lee TH; Concejero A; Hsu CJ
Acta Anaesthesiol Scand; 2006 Aug; 50(7):787-92. PubMed ID: 16879459
[TBL] [Abstract][Full Text] [Related]
14. The A118G single-nucleotide polymorphism of human μ-opioid receptor gene and use of labor analgesia.
Pettersson FD; Grönbladh A; Nyberg F; Sundström-Poromaa I; Åkerud H
Reprod Sci; 2012 Sep; 19(9):962-7. PubMed ID: 22527985
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological characterization of ethylenediamine synthetic opioids in human μ-opiate receptor 1 (OPRM1) expressing cells.
Hsu T; Mallareddy JR; Yoshida K; Bustamante V; Lee T; Krstenansky JL; Zambon AC
Pharmacol Res Perspect; 2019 Oct; 7(5):e00511. PubMed ID: 31463067
[TBL] [Abstract][Full Text] [Related]
16. μ-Opioid receptor gene (OPRM1) polymorphism in patients with breast cancer.
Cieślińska A; Sienkiewicz-Szłapka E; Kostyra E; Fiedorowicz E; Snarska J; Wroński K; Tenderenda M; Jarmołowska B; Matysiewicz M
Tumour Biol; 2015 Jun; 36(6):4655-60. PubMed ID: 25618602
[TBL] [Abstract][Full Text] [Related]
17. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Ca2+ channels by heterologously expressed wild-type and mutant human micro-opioid receptors (hMORs) containing the A118G single-nucleotide polymorphism.
Margas W; Zubkoff I; Schuler HG; Janicki PK; Ruiz-Velasco V
J Neurophysiol; 2007 Feb; 97(2):1058-67. PubMed ID: 17151221
[TBL] [Abstract][Full Text] [Related]
19. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
[TBL] [Abstract][Full Text] [Related]
20. Association of the OPRM1 and COMT genes' polymorphisms with the efficacy of morphine in Tunisian cancer patients: Impact of the high genetic heterogeneity in Tunisia?
Chatti I; Creveaux I; Woillard JB; Langlais S; Amara A; Ben Fatma L; Saad A; Gribaa M; Libert F
Therapie; 2016 Oct; 71(5):507-513. PubMed ID: 27288213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
